BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 6:10:00 PM | Browse: 1209 | Download: 1074
 |
Received |
|
2012-08-05 17:03 |
 |
Peer-Review Started |
|
2012-09-03 16:46 |
 |
To Make the First Decision |
|
2012-10-31 14:12 |
 |
Return for Revision |
|
2012-11-05 08:19 |
 |
Revised |
|
2012-11-05 19:34 |
 |
Second Decision |
|
2012-12-27 09:32 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2012-12-27 13:41 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2013-01-09 17:07 |
 |
Typeset the Manuscript |
|
2013-01-30 17:06 |
 |
Publish the Manuscript Online |
|
2013-02-06 11:36 |
Category |
Oncology |
Manuscript Type |
Meta-Analysis |
Article Title |
Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases
|
Manuscript Source |
Invited Manuscript |
All Author List |
De-Bang Li, Feng Ye, Xiu-Rong Wu, Lu-Peng Wu, Jing-Xi Chen, Bin Li and Yan-Ming Zhou |
Funding Agency and Grant Number |
|
Corresponding Author |
Yan-Ming Zhou, MD, Department of Hepatobiliary and Pancreatovascular Surgery, First Affiliated Hospital of Xiamen University, Oncologic Center of Xiamen, 55 Zhenhai Road, Xiamen 361003, Fujian Province, China. zhouyms@yahoo.com.cn |
Key Words |
Colorectal cancer; Liver metastases; Bevacizumab; Postoperative complication; Sinusoidal dilatation |
Core Tip |
|
Publish Date |
2013-02-06 11:36 |
Citation |
Li DB, Ye F, Wu XR, Wu LP, Chen JX, Li B, Zhou YM. Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases. World J Gastroenterol 2013; 19(5): 761-768 |
URL |
http://www.wjgnet.com/1007-9327/full/v19/i5/761.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v19.i5.761 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345